Richard Lipton
Payments from drug & device makers
Across 453 payments — averaging $3515.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$619K
- AbbVie$273K
- Lilly USA, LLC$169K
- Eli Lilly$111K
- Teva Pharmaceuticals USA, Inc.$102K
- Pfizer$84K
- plus $235K from 18 others
Across 49 payments — averaging $1842.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$55K
- Eli Lilly$19K
- Amgen$15K
- Novartis$750
What the payments were for
- Consulting fees$576,74577%
- Speaking & faculty fees$150,06820%
- Travel & lodging$17,0792%
- Food & beverage$5,6801%
- Education$3,1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 31 | $618,730 |
| AbbVie(2 entities) | 126 | $273,091 |
| Lilly USA, LLC | 75 | $168,840 |
| Eli Lilly | 37 | $110,575 |
| Teva Pharmaceuticals USA, Inc. | 51 | $102,225 |
| Pfizer | 33 | $84,372 |
| Grifols Shared Services North America, Inc. | 9 | $70,256 |
| H. Lundbeck A S | 33 | $62,847 |
| Ipsen Innovation | 22 | $24,451 |
| Lundbeck LLC | 10 | $21,149 |
| Biohaven Pharmaceuticals, Inc. | 5 | $20,000 |
| Novartis Pharma AG | 6 | $9,951 |
| Genentech, Inc. | 2 | $5,520 |
| Scilex Pharmaceuticals Inc. | 3 | $5,454 |
| Axsome Therapeutics, Inc. | 1 | $4,875 |
| Dr.reddy's Laboratories,inc. | 1 | $3,000 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $2,000 |
| Pfizer S.A. | 1 | $2,000 |
| Pfizer Chile S.A. | 1 | $1,600 |
| Tonix Medicines, Inc. | 1 | $1,200 |
| Biodelivery Sciences International, Inc. | 1 | $300 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| Promius Pharma LLC | 1 | $115 |
| Biogen | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$89,825
- UBRELVY$71,412
- VYEPTI$63,692
- Gamunex-C$40,993
- BOTOX$34,589
- AIMOVIG$33,116
- Albutein$27,763
- EMGALITY$19,550
- ZAVZPRET$14,258
- AJOVY$13,728
- QULIPTA$9,389
- AMG334A_AIMOVIG_NEUROSCIENCE$7,802
- ELYXYB - CELECOXIB$3,300
- REYVOW$3,000
- AMG334_AIMOVIG_NEUROSCIENCE$2,149
- ZEMBRACE SYMTOUCH$1,200
How this compares
$1,592,718 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other neurology in Bronx
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
- Krupa PandeyAlbany$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.